Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Pharmacotherapy for posttraumatic stress disorder.
D. J. Stein
, N. Zungu-Dirwayi
, Der Linden GJ van Der Linden GJ
, S. Seedat
Research output
:
Contribution to journal
›
Review article
›
peer-review
251
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy for posttraumatic stress disorder.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Posttraumatic Stress Disorder
100%
Pharmacotherapy
100%
Randomized Controlled Trial
46%
Quality of Life
15%
Anxiety-depression
15%
Placebo
15%
Psychotherapy
15%
Medication Use
15%
Response Predictors
15%
Posttraumatic Stress Symptoms
15%
Cochrane Collaboration
15%
Medication Effects
15%
Post-traumatic
15%
Medication Treatment
15%
Open-label Trial
7%
High Prevalence
7%
Clinically Significant
7%
Treatment Response
7%
Antidepressants
7%
Response to Treatment
7%
Relative Risk
7%
Non-responders
7%
MEDLINE
7%
Sensitivity Analysis
7%
Literature Search
7%
Methodological Limitations
7%
Causal Role
7%
Hyperarousal
7%
Personal Costs
7%
Societal Costs
7%
Geriatric Patients
7%
Trauma
7%
Large Trials
7%
Clinical Global Impression Scale
7%
Clinical Heterogeneity
7%
Scale Change
7%
Symptom Score
7%
Placebo-controlled Trial
7%
Psychological Trauma
7%
Continuous Measures
7%
Clinician Rating
7%
Re-experiencing
7%
Review Manager
7%
Dissertation Abstracts
7%
Methodological Heterogeneity
7%
Pharmaceutical Companies
7%
Comparative Trial
7%
Pediatric Subjects
7%
Weighted Mean Difference
7%
Test-negative Design
7%
Impact of Event Scale-Revised (IES-R)
7%
Self-report Scale
7%
Maintenance Medication
7%
Long-term Maintenance
7%
Comorbid Symptoms
7%
Total Scale
7%
Appropriate Dose
7%
Capture Data
7%
Anxiety Neurosis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Posttraumatic Stress Disorder
100%
Randomized Controlled Trial
40%
Diseases
26%
Placebo
20%
Open-Label Trial
6%
Base
6%
Prevalence
6%
Antidepressant
6%
Selective Serotonin Reuptake Inhibitor
6%
Anxiety Neurosis
6%
Psychological Trauma
6%
Neuroscience
Posttraumatic Stress Disorder
100%
Drug Therapy
100%
Randomized Controlled Trial
40%
Placebo
20%
Quality of Life
13%
Antidepressant
6%
Fight-or-Flight Response
6%
Selective Serotonin Reuptake Inhibitor
6%
Open-Label Trial
6%
Anxiety Neurosis
6%
Gerontology
6%
Psychological Trauma
6%
Systematic Review
6%
Psychology
Posttraumatic Stress Disorder
100%
Drug Therapy
100%
Quality of Life
13%
Cochrane Collaboration
13%
Self-Report
6%
Systematic Review
6%
Fight-or-Flight Response
6%
Neurosis
6%
Psychological Trauma
6%